Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.7350 (0.32%) ($4.5050 - $4.7350) on Thu. Aug. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.62% (three month average) | RSI | 73 | Latest Price | $4.7350(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 26.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) ACES(79%) XLU(71%) LIT(78%) ICLN(72%) EWP(60%) | Factors Impacting ATRA price | ATRA will decline at least -5.31% in a week (0% probabilities). TBT(-19%) UUP(-24%) USO(-7%) KWEB(2%) SHY(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.31% (StdDev 10.62%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.12(-7.52%) | 10 Day Moving Average | $4.72(0.32%) | 20 Day Moving Average | $3.97(19.27%) | To recent high | -46.1% | To recent low | 65.8% | Market Cap | $352m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |